Allogene Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Allogene Therapeutics by Bank of America Corporation
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.1M | 331k | 3.21 |
2023-09-30 | $2.7M | 837k | 3.17 |
2023-06-30 | $3.6M | 716k | 4.97 |
2023-03-31 | $5.1M | 1.0M | 4.94 |
2022-12-31 | $5.4M | 865k | 6.29 |
2022-06-30 | $3.1M | 268k | 11.40 |
2021-12-31 | $4.0M | 270k | 14.92 |
2021-06-30 | $4.3M | 163k | 26.07 |
2021-03-31 | $2.1M | 59k | 35.30 |
2020-12-31 | $8.6M | 339k | 25.24 |
2020-09-30 | $1.6M | 43k | 37.72 |
2020-06-30 | $2.1M | 49k | 42.82 |
2020-03-31 | $566k | 29k | 19.44 |
2019-12-31 | $740k | 29k | 25.96 |
2019-09-30 | $1.0M | 38k | 27.26 |
2019-03-31 | $2.7M | 95k | 28.90 |
2018-12-31 | $551k | 20k | 26.95 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation